Abstract

Desmopressin 4-mcg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2013 - Volume 17, Number 1

Page(s): 64

Download in electronic PDF format for $75
  • Desmopressin 4-mcg/mL Injection Page 1

Abstract

A formulation for preparing Desmopressin 4-mcg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • desmopressin acetate
  • synthetic octapeptide hormone
  • vasopressin analog
  • diabetes insipidus
  • bleeding
  • hemophilia A
  • primary nocturnal enuresis
  • von Willebrand disease type I

Related Categories

  • DIABETES
  • FORMULATIONS
  • PARENTERALS
  • STERILE PREPARATIONS
  • ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE
  • HEMOSTASIS, BLEEDING, ANTICOAGULATION

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jan/Feb 2013
Pg. 64
Desmopressin 4-mcg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 170-174
Five Compounds for Treating Diabetes-Related Conditions
Author(s): Meece Jerry
May/Jun 2000
Pg. 167
Desmopressin Acetate Nasal Solution 0.033 mg/mL
Author(s): Allen Loyd V Jr
Jan/Feb 2014
Pg. 69
Vasopressin 20-units/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2024
Pg. 509-514
Stability of Diluted Desmopressin Acetate Intranasal Solution at 0.01 mg/mL
Author(s): Friciu Mihaela, Bharadwaj Priyanshu, Bertrand Laurence, Roy-St-Pierre Émilie, Forest Jean-Marc, Leclair Grégoire
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Jan/Feb 2013
Pg. 72
Octreotide 50-mcg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2003
Pg. 188-191
Treating Canine Hepatic Disease
Author(s): Davidson Gigi S
Mar/Apr 2000
Pg. 88-90
Complications of Diabetes
Author(s): Key David M
Mar/Apr 2012
Pg. 157
Chromium 4-mcg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 2000
Pg. 103-104
Diabetes Book Reviews
Author(s): Reed-Kane Dana
Nov/Dec 2016
Pg. 447-454
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Author(s): Deleruyelle Laura J
Jan/Feb 2001
Pg. 52-54
Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Author(s): Ford Gina, Garcia Lea
Sep/Oct 2016
Pg. 359-364
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Author(s): Deleruyelle Laura J
Jan/Feb 2002
Pg. 44
Fentanyl 10-mcg/mL, Bupivacaine 5-mg/mL, and Baclofen 25-mcg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2012
Pg. 73
Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections
Author(s): Allen Loyd V Jr
Jan/Feb 2012
Pg. 75
Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections
Author(s): Allen Loyd V Jr
Jul/Aug 2011
Pg. 290-300
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review
Author(s): Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
Mar/Apr 2009
Pg. 161
Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 324
Calcitriol 1-mcg/mL Injection
Author(s): Allen Loyd V Jr